Free Trial
LON:OBI

Ondine Biomedical (OBI) Share Price, News & Analysis

Ondine Biomedical logo
C$8.70 -0.30 (-3.33%)
As of 05/30/2025 03:11 PM Eastern

About Ondine Biomedical Stock (LON:OBI)

Key Stats

Today's Range
C$8.16
C$8.75
50-Day Range
C$8.25
C$10.06
52-Week Range
C$5.50
C$13.30
Volume
89,471 shs
Average Volume
233,809 shs
Market Capitalization
C$62.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens. Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target. Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.

Receive OBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter.

OBI Stock News Headlines

How Trade Wars Are Creating Fresh Opportunities for Investors
Tariffs and trade tensions are back in the headlines, and while many are focused on the risks, smart investors know there’s also opportunity. New supply chain shifts, pricing power adjustments, and sector revaluations are already underway—creating openings for those who act early. That’s why we’ve just released our latest research: 📈 “From Tariffs to Returns: How to Capitalize on Trade Disputes in Your Portfolio”
See More Headlines

OBI Stock Analysis - Frequently Asked Questions

Ondine Biomedical's stock was trading at C$9.50 at the beginning of the year. Since then, OBI stock has decreased by 8.4% and is now trading at C$8.70.
View the best growth stocks for 2025 here
.

Shares of OBI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ondine Biomedical investors own include AutoZone (AZO), Intel (INTC), Premier African Minerals (PREM), Rolls-Royce Holdings plc (RR), TJX Companies (TJX), Abacus Health Products (ABAHF) and Aurora Cannabis (ACB).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:OBI
Previous Symbol
LON:OBI
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$424.66 thousand
Net Margins
-873.84%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$48,596.29
Cash Flow
C$4.37 per share
Price / Cash Flow
1.99
Book Value
C$0.01 per share
Price / Book
1,007.57

Miscellaneous

Free Float
N/A
Market Cap
C$62.55 million
Optionable
Not Optionable
Beta
0.10
Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (LON:OBI) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners